Header Logo

Jason M Glanz, PhD

TitleSenior Investigator
InstitutionKaiser Permanente Colorado
DepartmentInstitute for Health Research
Address2550 S. Parker Rd., Suite 200
Aurora CO 80014
ORCID ORCID Icon0000-0002-1950-7034 Additional info
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Jason M. Glanz, PhD, is a Senior Investigator at the Institute for Health Research. Dr. Glanz's research focuses on vaccine safety, vaccine acceptance, substance abuse, and epidemiological methods.

    Dr. Glanz earned his Master of Science degree in biostatistics from the University of Massachusetts Amherst and completed his doctoral training in epidemiology at the Colorado School of Public Health. He is a co-principal investigator for the Vaccine Safety Datalink (VSD), a nationwide Centers for Disease Control and Prevention-funded project that examines the safety of vaccines and leads research efforts to develop risk communication tools to reduce parental vaccination concerns. He is also co-leading a large randomized pragmatic trial examining the impact and safety of co-dispensing the overdose reversing medication naloxone with opioid prescriptions.

    Dr. Glanz is an Associate Clinical Professor of Epidemiology in the Department of Epidemiology at the University of Colorado School of Public Health.

    Collapse Research 
    Collapse research activities and funding
    KPCO RNG210746     (Binswanger/Glanz)Jun 1, 2020 - May 31, 2021
    Kaiser Permanente Garfield Memorial Fund
    Coronavirus Disease 2019 (COVID-19) Testing in Colorado: A Prospective Cohort in Kaiser Permanente Colorado
    Role: Co-Principal Investigator

    2UG1DA0403144-06S5     (Campbell)Jun 1, 2020 - Feb 28, 2021
    NIH/NIDA
    Determining the Optimal Duration of Buprenorphine Treatment to Reduce the Risk of Relapse, Overdose, and Mortality"
    Role: Co-Principal Investigator

    200-2012-53582/0010     (Glanz)May 7, 2020 - May 6, 2021

    VSD Validation of Novel Coronavirus and High-Risk Conditions
    Role: Principal Investigator

    5R01DA042059-04S2     (Binswanger/Glanz)May 1, 2019 - Apr 30, 2021
    NIH/NIDA
    The Safety and Impact of Expanded Access to Naloxone in Health Systems
    Role: Principal Investigator

    5R01DA047537-02     (Binswanger/Glanz)Mar 15, 2019 - Dec 31, 2022
    NIH/NIDA
    Assessing the Safety and Effectiveness of Opioid Tapering in Large Health Systems
    Role: Co-Principal Investigator

    200-2012-53582     (Glanz)Sep 28, 2018 - Sep 19, 2022
    CDC/NCEZID
    Vaccine Safety Datalink (VSD) Shingrix
    Role: Principal Investigator

    200-2012-53582     (Daley)Sep 20, 2018 - Sep 19, 2020
    CDC/NCEZID
    Vaccine Safety Datalink (VSD) Flu Survey
    Role: Co-Principal Investigator

    200-2012-53582 (10)     (Glanz)Sep 28, 2017 - Sep 27, 2022
    CDC/NCEZID
    VSD Infrastructure
    Role: Principal Investigator

    1U01CE002791-05     (Binswanger/Glanz)Sep 1, 2017 - Aug 31, 2020
    CDC/NCIPC
    Assessing the Unintended Consequences of Restrictive Opioid Pain Reliever
    Role: Principal Investigator

    5R01DA042059-05     (Binswanger/Glanz)Aug 1, 2016 - Apr 30, 2021
    NIH/NIDA
    The Safety and Impact of Expanded Access to Naloxone in Health Systems
    Role: Principal Investigator

    200-2012-53582 (TO 0009)     (Daley)Sep 25, 2015 - Sep 24, 2020
    CDC
    Vaccine Safety Datalink (VSD) Under-Vaccinated Children
    Role: Co-Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Klein NP, Lewis N, Goddard K, Fireman B, Zerbo O, Hanson KE, Donahue JG, Kharbanda EO, Naleway A, Nelson JC, Xu S, Yih WK, Glanz JM, Williams JTB, Hambidge SJ, Lewin BJ, Shimabukuro TT, DeStefano F, Weintraub ES. Surveillance for Adverse Events After COVID-19 mRNA Vaccination. JAMA. 2021 Sep 03. PMID: 34477808.
      Citations:    
    2. Wagner NM, Binswanger IA, Shetterly SM, Rinehart DJ, Wain KF, Hopfer C, Glanz JM. Development and validation of a prediction model for opioid use disorder among youth. Drug Alcohol Depend. 2021 Aug 28; 227:108980. PMID: 34482048.
      Citations:    
    3. Kwan BM, Pyrzanowski J, Sevick C, Wagner NM, Resnicow K, Glanz JM, Dempsey AF. Exploring mechanisms of a web-based values-tailored childhood vaccine promotion intervention trial: Effects on parental vaccination values, attitudes, and intentions. Appl Psychol Health Well Being. 2021 Aug 16. PMID: 34396709.
      Citations:    
    4. Pingali C, Meghani M, Razzaghi H, Lamias MJ, Weintraub E, Kenigsberg TA, Klein NP, Lewis N, Fireman B, Zerbo O, Bartlett J, Goddard K, Donahue J, Hanson K, Naleway A, Kharbanda EO, Yih WK, Nelson JC, Lewin BJ, Williams JTB, Glanz JM, Singleton JA, Patel SA. COVID-19 Vaccination Coverage Among Insured Persons Aged =16 Years, by Race/Ethnicity and Other Selected Characteristics - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 15, 2021. MMWR Morb Mortal Wkly Rep. 2021 Jul 16; 70(28):985-990. PMID: 34264911; PMCID: PMC8314710.
      Citations:    
    5. Xu S, Clarke CL, Newcomer SR, Daley MF, Glanz JM. Sensitivity analyses of unmeasured and partially-measured confounders using multiple imputation in a vaccine safety study. Pharmacoepidemiol Drug Saf. 2021 Sep; 30(9):1200-1213. PMID: 33988275.
      Citations:    
    6. Wagner NM, Dempsey AF, Narwaney KJ, Gleason KS, Kraus CR, Pyrzanowski J, Glanz JM. Addressing logistical barriers to childhood vaccination using an automated reminder system and online resource intervention: A randomized controlled trial. Vaccine. 2021 06 29; 39(29):3983-3990. PMID: 34059372; PMCID: PMC8237696.
      Citations:    
    7. Daley MF, Glanz JM. Using Social Media to Increase Vaccine Acceptance. Acad Pediatr. 2021 May-Jun; 21(4S):S32-S33. PMID: 33958089.
      Citations:    
    8. Daley MF, Reifler LM, Shoup JA, Narwaney KJ, Kharbanda EO, Groom HC, Jackson ML, Jacobsen SJ, McLean HQ, Klein NP, Williams JTB, Weintraub ES, McNeil MM, Glanz JM. Temporal Trends in Undervaccination: A Population-Based Cohort Study. Am J Prev Med. 2021 07; 61(1):64-72. PMID: 34148627.
      Citations:    
    9. Kharbanda EO, Vazquez-Benitez G, DeSilva MB, Naleway AL, Klein NP, Hechter RC, Glanz JM, Donahue JG, Jackson LA, Sheth SS, Greenberg V, Panagiotakopoulos L, Mba-Jonas A, Lipkind HS. Association of Inadvertent 9-Valent Human Papillomavirus Vaccine in Pregnancy With Spontaneous Abortion and Adverse Birth Outcomes. JAMA Netw Open. 2021 04 01; 4(4):e214340. PMID: 33818618; PMCID: PMC8022219.
      Citations:    
    10. Mueller SR, Glanz JM, Nguyen AP, Stowell M, Koester S, Rinehart DJ, Binswanger IA. Restrictive opioid prescribing policies and evolving risk environments: A qualitative study of the perspectives of patients who experienced an accidental opioid overdose. Int J Drug Policy. 2021 06; 92:103077. PMID: 33423916.
      Citations:    
    11. Derington CG, Mueller SR, Glanz JM, Binswanger IA. Identifying naloxone administrations in electronic health record data using a text-mining tool. Subst Abus. 2020 Dec 15; 1-10. PMID: 33320803; PMCID: PMC8203755.
      Citations:    
    12. Panagiotakopoulos L, McCarthy NL, Tepper NK, Kharbanda EO, Lipkind HS, Vazquez-Benitez G, McClure DL, Greenberg V, Getahun D, Glanz JM, Naleway AL, Klein NP, Nelson JC, Weintraub ES. Evaluating the Association of Stillbirths After Maternal Vaccination in the Vaccine Safety Datalink. Obstet Gynecol. 2020 12; 136(6):1086-1094. PMID: 33156197; PMCID: PMC8108006.
      Citations:    
    13. Glanz JM, Wagner NM, Narwaney KJ, Pyrzanowski J, Kwan BM, Sevick C, Resnicow K, Dempsey AF. Web-Based Tailored Messaging to Increase Vaccination: A Randomized Clinical Trial. Pediatrics. 2020 11; 146(5). PMID: 33046584; PMCID: PMC7605085.
      Citations:    
    14. Shoup JA, Mueller SR, Binswanger IA, Williams AV, Strang J, Glanz JM. Modifying and Evaluating the Opioid Overdose Knowledge Scale for Prescription Opioids: A Pilot Study of the Rx-OOKS. Pain Med. 2020 10 01; 21(10):2244-2252. PMID: 32827044; PMCID: PMC7593800.
      Citations:    
    15. Wang SV, Stefanini K, Lewis E, Newcomer SR, Fireman B, Daley MF, Glanz JM, Duffy J, Weintraub E, Kulldorff M. Determining Which of Several Simultaneously Administered Vaccines Increase Risk of an Adverse Event. Drug Saf. 2020 10; 43(10):1057-1065. PMID: 32613596; PMCID: PMC7501163.
      Citations:    
    16. Panagiotakopoulos L, Myers TR, Gee J, Lipkind HS, Kharbanda EO, Ryan DS, Williams JTB, Naleway AL, Klein NP, Hambidge SJ, Jacobsen SJ, Glanz JM, Jackson LA, Shimabukuro TT, Weintraub ES. SARS-CoV-2 Infection Among Hospitalized Pregnant Women: Reasons for Admission and Pregnancy Characteristics - Eight U.S. Health Care Centers, March 1-May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020 Sep 23; 69(38):1355-1359. PMID: 32970660; PMCID: PMC7727498.
      Citations:    
    17. Binswanger IA, Glanz JM, Faul M, Shoup JA, Quintana LM, Lyden J, Xu S, Narwaney KJ. The Association between Opioid Discontinuation and Heroin Use: A Nested Case-Control Study. Drug Alcohol Depend. 2020 12 01; 217:108248. PMID: 32927194.
      Citations:    
    18. Glanz JM, Clarke CL, Xu S, Daley MF, Shoup JA, Schroeder EB, Lewin BJ, McClure DL, Kharbanda E, Klein NP, DeStefano F. Association Between Rotavirus Vaccination and Type 1 Diabetes in Children. JAMA Pediatr. 2020 05 01; 174(5):455-462. PMID: 32150236; PMCID: PMC7063538.
      Citations:    
    19. Dempsey A, Kwan BM, Wagner NM, Pyrzanowski J, Brewer SE, Sevick C, Narwaney K, Resnicow K, Glanz J. A Values-Tailored Web-Based Intervention for New Mothers to Increase Infant Vaccine Uptake: Development and Qualitative Study. J Med Internet Res. 2020 03 05; 22(3):e15800. PMID: 32134394; PMCID: PMC7082734.
      Citations:    
    20. Nguyen AP, Glanz JM, Narwaney KJ, Binswanger IA. Association of Opioids Prescribed to Family Members With Opioid Overdose Among Adolescents and Young Adults. JAMA Netw Open. 2020 03 02; 3(3):e201018. PMID: 32219404; PMCID: PMC7462253.
      Citations:    
    21. Newcomer SR, Daley MF, Narwaney KJ, Xu S, DeStefano F, Groom HC, Jackson ML, Lewin BJ, McLean HQ, Nordin JD, Zerbo O, Glanz JM. Order of Live and Inactivated Vaccines and Risk of Non-vaccine-targeted Infections in US Children 11-23 Months of Age. Pediatr Infect Dis J. 2020 03; 39(3):247-253. PMID: 32032310.
      Citations:    
    22. King JP, Hanson KE, Donahue JG, Glanz JM, Klein NP, Naleway AL, DeStefano F, Weintraub E, Belongia EA. Survey of influenza vaccine knowledge, attitudes, and beliefs among pregnant women in the 2016-17 season. Vaccine. 2020 02 24; 38(9):2202-2208. PMID: 31992481; PMCID: PMC7869019.
      Citations:    
    23. Plotkin SA, Offit PA, DeStefano F, Larson HJ, Arora NK, Zuber PLF, Fombonne E, Sejvar J, Lambert PH, Hviid A, Halsey N, Garçon N, Peden K, Pollard AJ, Markowitz LE, Glanz J. The science of vaccine safety: Summary of meeting at Wellcome Trust. Vaccine. 2020 02 18; 38(8):1869-1880. PMID: 31987690.
      Citations:    
    24. Newcomer SR, Xu S, Kulldorff M, Daley MF, Fireman B, Glanz JM. A primer on quantitative bias analysis with positive predictive values in research using electronic health data. J Am Med Inform Assoc. 2019 12 01; 26(12):1664-1674. PMID: 31365086; PMCID: PMC6857512.
      Citations:    
    25. Donahue JG, Kieke BA, King JP, Mascola MA, Shimabukuro TT, DeStefano F, Hanson KE, McClure DL, Olaiya O, Glanz JM, Hechter RC, Irving SA, Jackson LA, Klein NP, Naleway AL, Weintraub ES, Belongia EA. Inactivated influenza vaccine and spontaneous abortion in the Vaccine Safety Datalink in 2012-13, 2013-14, and 2014-15. Vaccine. 2019 10 16; 37(44):6673-6681. PMID: 31540812; PMCID: PMC6906603.
      Citations:    
    26. O'Leary ST, Narwaney KJ, Wagner NM, Kraus CR, Omer SB, Glanz JM. Efficacy of a Web-Based Intervention to Increase Uptake of Maternal Vaccines: An RCT. Am J Prev Med. 2019 10; 57(4):e125-e133. PMID: 31471001.
      Citations:    
    27. Cataldi JR, Sevick C, Pyrzanowski J, Wagner N, Brewer SE, Narwaney KJ, Shoup JA, Resnicow K, Glanz J, Dempsey A, Kwan BM. Addressing personal parental values in decisions about childhood vaccination: Measure development. Vaccine. 2019 09 10; 37(38):5688-5697. PMID: 31421930; PMCID: PMC6752201.
      Citations:    
    28. Dempsey AF, Wagner N, Narwaney K, Pyrzanowski J, Kwan BM, Kraus C, Gleason K, Resnicow K, Sevick C, Cataldi J, Brewer SE, Glanz JM. 'Reducing Delays In Vaccination' (REDIVAC) trial: a protocol for a randomised controlled trial of a web-based, individually tailored, educational intervention to improve timeliness of infant vaccination. BMJ Open. 2019 05 22; 9(5):e027968. PMID: 31122997; PMCID: PMC6538084.
      Citations:    
    29. Glanz JM, Binswanger IA, Shetterly SM, Narwaney KJ, Xu S. Association Between Opioid Dose Variability and Opioid Overdose Among Adults Prescribed Long-term Opioid Therapy. JAMA Netw Open. 2019 Apr 05; 2(4):e192613. PMID: 31002325.
      Citations:    
    30. Binswanger IA, Narwaney KJ, Gardner EM, Gabella BA, Calcaterra SL, Glanz JM. Development and evaluation of a standardized research definition for opioid overdose outcomes. Subst Abus. 2019 Mar 15; 1-9. PMID: 30875477.
      Citations:    
    31. Xu S, Newcomer SR, Kulldorff M, Daley MF, Fireman B, Glanz JM. Use of three summary measures of pediatric vaccination for studying the safety of the childhood immunization schedule. Vaccine. 2019 Feb 28; 37(10):1325-1331. PMID: 30709727.
      Citations:    
    32. Shoup JA, Narwaney KJ, Wagner NM, Kraus CR, Gleason KS, Albright K, Glanz JM. Social Media Vaccine Websites: A Comparative Analysis of Public and Moderated Websites. Health Educ Behav. 2018 Dec 29; 1090198118818253. PMID: 30596265.
      Citations:    
    33. McClure DL, Jacobsen SJ, Klein NP, Naleway AL, Kharbanda EO, Glanz JM, Jackson LA, Weintraub ES, McLean HQ. Similar relative risks of seizures following measles containing vaccination in children born preterm compared to full-term without previous seizures or seizure-related disorders. Vaccine. 2019 Jan 03; 37(1):76-79. PMID: 30478005.
      Citations:    
    34. Binswanger IA, Joseph N, Hanratty R, Gardner EM, Durfee J, Narwaney KJ, Breslin K, Mueller SR, Glanz JM. Novel Opioid Safety Clinic Initiative to Deliver Guideline-Concordant Chronic Opioid Therapy in Primary Care. Mayo Clin Proc Innov Qual Outcomes. 2018 Dec; 2(4):309-316. PMID: 30560232.
      Citations:    
    35. Binswanger IA, Glanz JM. Potential Risk Window for Opioid Overdose Related to Treatment with Extended-Release Injectable Naltrexone. Drug Saf. 2018 10; 41(10):979-980. PMID: 30073490.
      Citations:    
    36. Jackson ML, Yu O, Nelson JC, Nordin JD, Tartof SY, Klein NP, Donahue JG, Irving SA, Glanz JM, McNeil MM, Jackson LA. Safety of repeated doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine in adults and adolescents. Pharmacoepidemiol Drug Saf. 2018 Aug; 27(8):921-925. PMID: 29862604.
      Citations:    
    37. Xu S, Clarke CL, Newcomer SR, Daley MF, Glanz JM. Analyzing self-controlled case series data when case confirmation rates are estimated from an internal validation sample. Biom J. 2018 07; 60(4):748-760. PMID: 29768667.
      Citations:    
    38. Daley MF, Narwaney KJ, Shoup JA, Wagner NM, Glanz JM. Addressing Parents' Vaccine Concerns: A Randomized Trial of a Social Media Intervention. Am J Prev Med. 2018 Jul; 55(1):44-54. PMID: 29773490.
      Citations:    
    39. Daley MF, Shoup JA, Newcomer SR, Jackson ML, Groom HC, Jacobsen SJ, McLean HQ, Klein NP, Weintraub ES, McNeil MM, Glanz JM. Assessing Potential Confounding and Misclassification Bias When Studying the Safety of the Childhood Immunization Schedule. Acad Pediatr. 2018 Sep - Oct; 18(7):754-762. PMID: 29604461.
      Citations:    
    40. Glanz JM, Newcomer SR, Daley MF, DeStefano F, Groom HC, Jackson ML, Lewin BJ, McCarthy NL, McClure DL, Narwaney KJ, Nordin JD, Zerbo O. Association Between Estimated Cumulative Vaccine Antigen Exposure Through the First 23 Months of Life and Non-Vaccine-Targeted Infections From 24 Through 47 Months of Age. JAMA. 2018 03 06; 319(9):906-913. PMID: 29509866.
      Citations:    
    41. Sukumaran L, McCarthy NL, Kharbanda EO, Vazquez-Benitez G, Lipkind HS, Jackson L, Klein NP, Naleway AL, McClure DL, Hechter RC, Kawai AT, Glanz JM, Weintraub ES. Infant Hospitalizations and Mortality After Maternal Vaccination. Pediatrics. 2018 03; 141(3). PMID: 29463582.
      Citations:    
    42. Zhou H, Thompson WW, Belongia EA, Fowlkes A, Baxter R, Jacobsen SJ, Jackson ML, Glanz JM, Naleway AL, Ford DC, Weintraub E, Shay DK. Estimated rates of influenza-associated outpatient visits during 2001-2010 in 6 US integrated healthcare delivery organizations. Influenza Other Respir Viruses. 2018 01; 12(1):122-131. PMID: 28960732.
      Citations:    
    43. Wang SV, Abdurrob A, Spoendlin J, Lewis E, Newcomer SR, Fireman B, Daley MF, Glanz JM, Duffy J, Weintraub ES, Kulldorff M. Methods for addressing "innocent bystanders" when evaluating safety of concomitant vaccines. Pharmacoepidemiol Drug Saf. 2018 Apr; 27(4):405-412. PMID: 29441647.
      Citations:    
    44. Glanz JM, Narwaney KJ, Mueller SR, Gardner EM, Calcaterra SL, Xu S, Breslin K, Binswanger IA. Prediction Model for Two-Year Risk of Opioid Overdose Among Patients Prescribed Chronic Opioid Therapy. J Gen Intern Med. 2018 Oct; 33(10):1646-1653. PMID: 29380216.
      Citations:    
    45. Newcomer SR, Kulldorff M, Xu S, Daley MF, Fireman B, Lewis E, Glanz JM. Bias from outcome misclassification in immunization schedule safety research. Pharmacoepidemiol Drug Saf. 2018 Feb; 27(2):221-228. PMID: 29292551.
      Citations:    
    46. Storms AD, Chen J, Jackson LA, Nordin JD, Naleway AL, Glanz JM, Jacobsen SJ, Weintraub ES, Klein NP, Gargiullo PM, Fry AM. Rates and risk factors associated with hospitalization for pneumonia with ICU admission among adults. BMC Pulm Med. 2017 Dec 16; 17(1):208. PMID: 29246210.
      Citations:    
    47. Daley MF, Clarke CL, Glanz JM, Xu S, Hambidge SJ, Donahue JG, Nordin JD, Klein NP, Jacobsen SJ, Naleway AL, Jackson ML, Lee G, Duffy J, Weintraub E. The safety of live attenuated influenza vaccine in children and adolescents 2 through 17 years of age: A Vaccine Safety Datalink study. Pharmacoepidemiol Drug Saf. 2018 Jan; 27(1):59-68. PMID: 29148124.
      Citations:    
    48. Glanz JM, Wagner NM, Narwaney KJ, Kraus CR, Shoup JA, Xu S, O'Leary ST, Omer SB, Gleason KS, Daley MF. Web-based Social Media Intervention to Increase Vaccine Acceptance: A Randomized Controlled Trial. Pediatrics. 2017 Dec; 140(6). PMID: 29109107.
      Citations:    
    49. McCarthy NL, Sukumaran L, Newcomer S, Glanz J, Daley MF, McClure D, Klein NP, Irving S, Jackson ML, Lewin B, Weintraub E. Patterns of childhood immunization and all-cause mortality. Vaccine. 2017 12 04; 35(48 Pt B):6643-6648. PMID: 29061349.
      Citations:    
    50. Donahue JG, Kieke BA, King JP, DeStefano F, Mascola MA, Irving SA, Cheetham TC, Glanz JM, Jackson LA, Klein NP, Naleway AL, Weintraub E, Belongia EA. Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010-11 and 2011-12. Vaccine. 2017 09 25; 35(40):5314-5322. PMID: 28917295.
      Citations:    
    51. Vickers ER, McClure DL, Naleway AL, Jacobsen SJ, Klein NP, Glanz JM, Weintraub ES, Belongia EA. Risk of venous thromboembolism following influenza vaccination in adults aged 50years and older in the Vaccine Safety Datalink. Vaccine. 2017 10 13; 35(43):5872-5877. PMID: 28888342.
      Citations:    
    52. Daley MF, Glanz JM, Newcomer SR, Jackson ML, Groom HC, Lugg MM, McLean HQ, Klein NP, Weintraub ES, McNeil MM. Assessing misclassification of vaccination status: Implications for studies of the safety of the childhood immunization schedule. Vaccine. 2017 04 04; 35(15):1873-1878. PMID: 28285983.
      Citations:    
    53. Klein NP, Lewis E, McDonald J, Fireman B, Naleway A, Glanz J, Jackson LA, Donahue JG, Jacobsen SJ, Weintraub E, Baxter R. Risk factors and familial clustering for fever 7-10days after the first dose of measles vaccines. Vaccine. 2017 03 14; 35(12):1615-1621. PMID: 28233624.
      Citations:    
    54. Mueller SR, Koester S, Glanz JM, Gardner EM, Binswanger IA. Attitudes Toward Naloxone Prescribing in Clinical Settings: A Qualitative Study of Patients Prescribed High Dose Opioids for Chronic Non-Cancer Pain. J Gen Intern Med. 2017 Mar; 32(3):277-283. PMID: 27798775.
      Citations:    
    55. Glanz JM, Newcomer SR, Jackson ML, Omer SB, Bednarczyk RA, Shoup JA, DeStefano F, Daley MF. White Paper on studying the safety of the childhood immunization schedule in the Vaccine Safety Datalink. Vaccine. 2016 Feb 15; 34 Suppl 1:A1-A29. PMID: 26830300.
      Citations:    
    56. Binswanger IA, Koester S, Mueller SR, Gardner EM, Goddard K, Glanz JM. Overdose Education and Naloxone for Patients Prescribed Opioids in Primary Care: A Qualitative Study of Primary Care Staff. J Gen Intern Med. 2015 Dec; 30(12):1837-44. PMID: 26055224.
      Citations:    
    57. Salmon DA, Dudley MZ, Glanz JM, Omer SB. Vaccine hesitancy: Causes, consequences, and a call to action. Vaccine. 2015 Nov 27; 33 Suppl 4:D66-71. PMID: 26615171.
      Citations:    
    58. Groom HC, Henninger ML, Smith N, Koppolu P, Cheetham TC, Glanz JM, Hambidge SJ, Jackson LA, Kharbanda EO, Klein NP, McCarthy NL, Nordin JD, Weintraub ES, Naleway AL. Influenza Vaccination During Pregnancy: Influenza Seasons 2002-2012, Vaccine Safety Datalink. Am J Prev Med. 2016 Apr; 50(4):480-488. PMID: 26526159.
      Citations:    
    59. Glanz JM, Newcomer SR, Daley MF, McClure DL, Baxter RP, Jackson ML, Naleway AL, Lugg MM, DeStefano F. Cumulative and episodic vaccine aluminum exposure in a population-based cohort of young children. Vaccine. 2015 Nov 27; 33(48):6736-44. PMID: 26518400.
      Citations:    
    60. Salmon DA, Dudley MZ, Glanz JM, Omer SB. Vaccine Hesitancy: Causes, Consequences, and a Call to Action. Am J Prev Med. 2015 Dec; 49(6 Suppl 4):S391-8. PMID: 26337116.
      Citations:    
    61. Glanz JM, Kraus CR, Daley MF. Addressing Parental Vaccine Concerns: Engagement, Balance, and Timing. PLoS Biol. 2015 Aug; 13(8):e1002227. PMID: 26252770.
      Citations:    
    62. Gaskin GL, Glanz JM, Binswanger IA, Anoshiravani A. Immunization Coverage Among Juvenile Justice Detainees. J Correct Health Care. 2015 Jul; 21(3):265-75. PMID: 26084948.
      Citations:    
    63. Mueller SR, Walley AY, Calcaterra SL, Glanz JM, Binswanger IA. A Review of Opioid Overdose Prevention and Naloxone Prescribing: Implications for Translating Community Programming Into Clinical Practice. Subst Abus. 2015; 36(2):240-53. PMID: 25774771.
      Citations:    
    64. Binswanger IA, Glanz JM. Pharmaceutical Opioids in the Home and Youth: Implications for Adult Medical Practice. Subst Abus. 2015; 36(2):141-3. PMID: 25671706.
      Citations:    
    65. Shoup JA, Wagner NM, Kraus CR, Narwaney KJ, Goddard KS, Glanz JM. Development of an interactive social media tool for parents with concerns about vaccines. Health Educ Behav. 2015 Jun; 42(3):302-12. PMID: 25413375.
      Citations:    
    66. McNeil MM, Gee J, Weintraub ES, Belongia EA, Lee GM, Glanz JM, Nordin JD, Klein NP, Baxter R, Naleway AL, Jackson LA, Omer SB, Jacobsen SJ, DeStefano F. The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety. Vaccine. 2014 Sep 22; 32(42):5390-8. PMID: 25108215.
      Citations:    
    67. Hambidge SJ, Newcomer SR, Narwaney KJ, Glanz JM, Daley MF, Xu S, Shoup JA, Rowhani-Rahbar A, Klein NP, Lee GM, Nelson JC, Lugg M, Naleway AL, Nordin JD, Weintraub E, DeStefano F. Timely versus delayed early childhood vaccination and seizures. Pediatrics. 2014 Jun; 133(6):e1492-9. PMID: 24843064.
      Citations:    
    68. Daley MF, Yih WK, Glanz JM, Hambidge SJ, Narwaney KJ, Yin R, Li L, Nelson JC, Nordin JD, Klein NP, Jacobsen SJ, Weintraub E. Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine. Vaccine. 2014 May 23; 32(25):3019-24. PMID: 24699471.
      Citations:    
    69. Naleway AL, Kurosky S, Henninger ML, Gold R, Nordin JD, Kharbanda EO, Irving S, Craig Cheetham T, Nakasato C, Glanz JM, Hambidge SJ, Davis RL, Klein NP, McCarthy NL, Weintraub E. Vaccinations given during pregnancy, 2002-2009: a descriptive study. Am J Prev Med. 2014 Feb; 46(2):150-7. PMID: 24439348.
      Citations:    
    70. Weintraub ES, Baggs J, Duffy J, Vellozzi C, Belongia EA, Irving S, Klein NP, Glanz JM, Jacobsen SJ, Naleway A, Jackson LA, DeStefano F. Risk of intussusception after monovalent rotavirus vaccination. N Engl J Med. 2014 Feb 06; 370(6):513-9. PMID: 24422678.
      Citations:    
    71. Xu S, Newcomer S, Nelson J, Qian L, McClure D, Pan Y, Zeng C, Glanz J. Signal detection of adverse events with imperfect confirmation rates in vaccine safety studies using self-controlled case series design. Biom J. 2014 May; 56(3):513-25. PMID: 24402780.
      Citations:    
    72. McClure DL, Raebel MA, Yih WK, Shoaibi A, Mullersman JE, Anderson-Smits C, Glanz JM. Mini-Sentinel methods: framework for assessment of positive results from signal refinement. Pharmacoepidemiol Drug Saf. 2014 Jan; 23(1):3-8. PMID: 24395545.
      Citations:    
    73. Payne DC, Baggs J, Zerr DM, Klein NP, Yih K, Glanz J, Curns AT, Weintraub E, Parashar UD. Protective association between rotavirus vaccination and childhood seizures in the year following vaccination in US children. Clin Infect Dis. 2014 Jan; 58(2):173-7. PMID: 24265355.
      Citations:    
    74. Glanz JM, Narwaney KJ, Newcomer SR, Daley MF, Hambidge SJ, Rowhani-Rahbar A, Lee GM, Nelson JC, Naleway AL, Nordin JD, Lugg MM, Weintraub ES. Association between undervaccination with diphtheria, tetanus toxoids, and acellular pertussis (DTaP) vaccine and risk of pertussis infection in children 3 to 36 months of age. JAMA Pediatr. 2013 Nov; 167(11):1060-4. PMID: 24019039.
      Citations:    
    75. Zeng C, Newcomer SR, Glanz JM, Shoup JA, Daley MF, Hambidge SJ, Xu S. Bias correction of risk estimates in vaccine safety studies with rare adverse events using a self-controlled case series design. Am J Epidemiol. 2013 Dec 15; 178(12):1750-9. PMID: 24327463.
      Citations:    
    76. Glanz JM, Wagner NM, Narwaney KJ, Shoup JA, McClure DL, McCormick EV, Daley MF. A mixed methods study of parental vaccine decision making and parent-provider trust. Acad Pediatr. 2013 Sep-Oct; 13(5):481-8. PMID: 24011751.
      Citations:    
    77. Sadaf A, Richards JL, Glanz J, Salmon DA, Omer SB. A systematic review of interventions for reducing parental vaccine refusal and vaccine hesitancy. Vaccine. 2013 Sep 13; 31(40):4293-304. PMID: 23859839.
      Citations:    
    78. Newcomer SR, Hambidge SJ, McClure DL, Daley MF, Klein NP, Glanz JM. Factors that may explain observed associations between trivalent influenza vaccination and gastrointestinal illness in young children. Vaccine. 2013 Aug 20; 31(37):3894-8. PMID: 23831326.
      Citations:    
    79. McCarthy NL, Weintraub E, Vellozzi C, Duffy J, Gee J, Donahue JG, Jackson ML, Lee GM, Glanz J, Baxter R, Lugg MM, Naleway A, Omer SB, Nakasato C, Vazquez-Benitez G, DeStefano F. Mortality rates and cause-of-death patterns in a vaccinated population. Am J Prev Med. 2013 Jul; 45(1):91-97. PMID: 23790993.
      Citations:    
    80. Daley MF, Sinaiko AR, Reifler LM, Tavel HM, Glanz JM, Margolis KL, Parker E, Trower NK, Chandra M, Sherwood NE, Adams K, Kharbanda EO, Greenspan LC, Lo JC, O'Connor PJ, Magid DJ. Patterns of care and persistence after incident elevated blood pressure. Pediatrics. 2013 Aug; 132(2):e349-55. PMID: 23821694.
      Citations:    
    81. Tseng HF, Sy LS, Liu IL, Qian L, Marcy SM, Weintraub E, Yih K, Baxter R, Glanz JM, Donahue J, Naleway A, Nordin J, Jacobsen SJ. Postlicensure surveillance for pre-specified adverse events following the 13-valent pneumococcal conjugate vaccine in children. Vaccine. 2013 May 24; 31(22):2578-83. PMID: 23579258.
      Citations:    
    82. Glanz JM, Newcomer SR, Narwaney KJ, Hambidge SJ, Daley MF, Wagner NM, McClure DL, Xu S, Rowhani-Rahbar A, Lee GM, Nelson JC, Donahue JG, Naleway AL, Nordin JD, Lugg MM, Weintraub ES. A population-based cohort study of undervaccination in 8 managed care organizations across the United States. JAMA Pediatr. 2013 Mar 01; 167(3):274-81. PMID: 23338829.
      Citations:    
    83. Xu S, Hambidge SJ, McClure DL, Daley MF, Glanz JM. A scan statistic for identifying optimal risk windows in vaccine safety studies using self-controlled case series design. Stat Med. 2013 Aug 30; 32(19):3290-9. PMID: 23303643.
      Citations:    
    84. Calcaterra S, Glanz J, Binswanger IA. National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999-2009. Drug Alcohol Depend. 2013 Aug 01; 131(3):263-70. PMID: 23294765.
      Citations:    
    85. Irving SA, Kieke BA, Donahue JG, Mascola MA, Baggs J, DeStefano F, Cheetham TC, Jackson LA, Naleway AL, Glanz JM, Nordin JD, Belongia EA. Trivalent inactivated influenza vaccine and spontaneous abortion. Obstet Gynecol. 2013 Jan; 121(1):159-65. PMID: 23262941.
      Citations:    
    86. Narwaney KJ, Glanz JM, Norris JM, Fingerlin TE, Hokanson JE, Rewers M, Hambidge SJ. Association of HLA class II genes with clinical hyporesponsiveness to trivalent inactivated influenza vaccine in children. Vaccine. 2013 Feb 04; 31(7):1123-8. PMID: 23261040.
      Citations:    
    87. Tseng HF, Sy LS, Qian L, Marcy SM, Jackson LA, Glanz J, Nordin J, Baxter R, Naleway A, Donahue J, Weintraub E, Jacobsen SJ. Safety of a tetanus-diphtheria-acellular pertussis vaccine when used off-label in an elderly population. Clin Infect Dis. 2013 Feb; 56(3):315-21. PMID: 23196953.
      Citations:    
    88. Kahn MG, Raebel MA, Glanz JM, Riedlinger K, Steiner JF. A pragmatic framework for single-site and multisite data quality assessment in electronic health record-based clinical research. Med Care. 2012 Jul; 50 Suppl:S21-9. PMID: 22692254.
      Citations:    
    89. Greene SK, Shay DK, Yin R, McCarthy NL, Baxter R, Jackson ML, Jacobsen SJ, Nordin JD, Irving SA, Naleway AL, Glanz JM, Lieu TA. Patterns in influenza antiviral medication use before and during the 2009 H1N1 pandemic, Vaccine Safety Datalink Project, 2000-2010. Influenza Other Respir Viruses. 2012 Nov; 6(6):e143-51. PMID: 22687171.
      Citations:    
    90. McClure DL, Xu S, Weintraub E, Glanz JM. An efficient statistical algorithm for a temporal scan statistic applied to vaccine safety analyses. Vaccine. 2012 Jun 08; 30(27):3986-91. PMID: 22531555.
      Citations:    
    91. Xu S, Zeng C, Newcomer S, Nelson J, Glanz J. Use of Fixed Effects Models to Analyze Self-Controlled Case Series Data in Vaccine Safety Studies. J Biom Biostat. 2012 Apr 19; Suppl 7:006. PMID: 24707443.
      Citations:    
    92. Klein NP, Lewis E, Baxter R, Weintraub E, Glanz J, Naleway A, Jackson LA, Nordin J, Lieu T, Belongia EA, Fireman B. Measles-containing vaccines and febrile seizures in children age 4 to 6 years. Pediatrics. 2012 May; 129(5):809-14. PMID: 22473362.
      Citations:    
    93. Binswanger IA, Nowels C, Corsi KF, Glanz J, Long J, Booth RE, Steiner JF. Return to drug use and overdose after release from prison: a qualitative study of risk and protective factors. Addict Sci Clin Pract. 2012; 7:3. PMID: 22966409.
      Citations:    
    94. Shui IM, Baggs J, Patel M, Parashar UD, Rett M, Belongia EA, Hambidge SJ, Glanz JM, Klein NP, Weintraub E. Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants. JAMA. 2012 Feb 08; 307(6):598-604. PMID: 22318281.
      Citations:    
    95. O'Leary ST, Glanz JM, McClure DL, Akhtar A, Daley MF, Nakasato C, Baxter R, Davis RL, Izurieta HS, Lieu TA, Ball R. The risk of immune thrombocytopenic purpura after vaccination in children and adolescents. Pediatrics. 2012 Feb; 129(2):248-55. PMID: 22232308.
      Citations:    
    96. Hambidge SJ, Ross C, Glanz J, McClure D, Daley MF, Xu S, Shoup JA, Narwaney K, Baggs J, Weintraub E. Trivalent inactivated influenza vaccine is not associated with sickle cell crises in children. Pediatrics. 2012 Jan; 129(1):e54-9. PMID: 22157132.
      Citations:    
    97. Hambidge SJ, Ross C, McClure D, Glanz J. Trivalent inactivated influenza vaccine is not associated with sickle cell hospitalizations in adults from a large cohort. Vaccine. 2011 Oct 26; 29(46):8179-81. PMID: 21930176.
      Citations:    
    98. Daley MF, Glanz JM. Straight talk about vaccination. Sci Am. 2011 Sep; 305(3):32, 34. PMID: 21870438.
      Citations:    
    99. Glanz JM, Newcomer SR, Hambidge SJ, Daley MF, Narwaney KJ, Xu S, Lee GM, Baggs J, Klein NP, Nordin JD, Naleway AL, Belongia EA, Weintraub ES. Safety of trivalent inactivated influenza vaccine in children aged 24 to 59 months in the vaccine safety datalink. Arch Pediatr Adolesc Med. 2011 Aug; 165(8):749-55. PMID: 21810637.
      Citations:    
    100. Nelson CA, France EK, Shetterly SM, Glanz JM. Seasonal influenza vaccination status among children with laboratory evidence of pandemic H1N1 infection. Pediatr Infect Dis J. 2011 Jul; 30(7):562-5. PMID: 21248657.
      Citations:    
    101. Baggs J, Gee J, Lewis E, Fowler G, Benson P, Lieu T, Naleway A, Klein NP, Baxter R, Belongia E, Glanz J, Hambidge SJ, Jacobsen SJ, Jackson L, Nordin J, Weintraub E. The Vaccine Safety Datalink: a model for monitoring immunization safety. Pediatrics. 2011 May; 127 Suppl 1:S45-53. PMID: 21502240.
      Citations:    
    102. Glanz JM, McClure DL, O'Leary ST, Narwaney KJ, Magid DJ, Daley MF, Hambidge SJ. Parental decline of pneumococcal vaccination and risk of pneumococcal related disease in children. Vaccine. 2011 Jan 29; 29(5):994-9. PMID: 21145372.
      Citations:    
    103. Xu S, Zhang L, Nelson JC, Zeng C, Mullooly J, McClure D, Glanz J. Identifying optimal risk windows for self-controlled case series studies of vaccine safety. Stat Med. 2011 Mar 30; 30(7):742-52. PMID: 21394750.
      Citations:    
    104. Glanz JM, McClure DL, Magid DJ, Daley MF, France EK, Hambidge SJ. Parental refusal of varicella vaccination and the associated risk of varicella infection in children. Arch Pediatr Adolesc Med. 2010 Jan; 164(1):66-70. PMID: 20048244.
      Citations:    
    105. Belongia EA, Irving SA, Shui IM, Kulldorff M, Lewis E, Yin R, Lieu TA, Weintraub E, Yih WK, Li R, Baggs J. Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine. Pediatr Infect Dis J. 2010 Jan; 29(1):1-5. PMID: 19907356.
      Citations:    
    106. Greene SK, Kulldorff M, Lewis EM, Li R, Yin R, Weintraub ES, Fireman BH, Lieu TA, Nordin JD, Glanz JM, Baxter R, Jacobsen SJ, Broder KR, Lee GM. Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project. Am J Epidemiol. 2010 Jan 15; 171(2):177-88. PMID: 19965887.
      Citations:    
    107. Naleway AL, Belongia EA, Donahue JG, Kieke BA, Glanz JM. Risk of immune hemolytic anemia in children following immunization. Vaccine. 2009 Dec 09; 27(52):7394-7. PMID: 19766577.
      Citations:    
    108. Glanz JM, McClure DL, Magid DJ, Daley MF, France EK, Salmon DA, Hambidge SJ. Parental refusal of pertussis vaccination is associated with an increased risk of pertussis infection in children. Pediatrics. 2009 Jun; 123(6):1446-51. PMID: 19482753.
      Citations:    
    109. Donahue JG, Kieke BA, Yih WK, Berger NR, McCauley JS, Baggs J, Zangwill KM, Baxter R, Eriksen EM, Glanz JM, Hambidge SJ, Klein NP, Lewis EM, Marcy SM, Naleway AL, Nordin JD, Ray P, Belongia EA. Varicella vaccination and ischemic stroke in children: is there an association? Pediatrics. 2009 Feb; 123(2):e228-34. PMID: 19171574.
      Citations:    
    110. McClure DL, Glanz JM, Xu S, Hambidge SJ, Mullooly JP, Baggs J. Comparison of epidemiologic methods for active surveillance of vaccine safety. Vaccine. 2008 Jun 19; 26(26):3341-5. PMID: 18462849.
      Citations:    
    111. Glanz J, France E, Xu S, Hayes T, Hambidge S. A population-based, multisite cohort study of the predictors of chronic idiopathic thrombocytopenic purpura in children. Pediatrics. 2008 Mar; 121(3):e506-12. PMID: 18310170.
      Citations:    
    112. France EK, Glanz J, Xu S, Hambidge S, Yamasaki K, Black SB, Marcy M, Mullooly JP, Jackson LA, Nordin J, Belongia EA, Hohman K, Chen RT, Davis R. Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children. Pediatrics. 2008 Mar; 121(3):e687-92. PMID: 18310189.
      Citations:    
    113. Hambidge SJ, Glanz JM, France EK, McClure D, Xu S, Yamasaki K, Jackson L, Mullooly JP, Zangwill KM, Marcy SM, Black SB, Lewis EM, Shinefield HR, Belongia E, Nordin J, Chen RT, Shay DK, Davis RL, DeStefano F. Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old. JAMA. 2006 Oct 25; 296(16):1990-7. PMID: 17062862.
      Citations:    
    114. Glanz JM, McClure DL, Xu S, Hambidge SJ, Lee M, Kolczak MS, Kleinman K, Mullooly JP, France EK. Four different study designs to evaluate vaccine safety were equally validated with contrasting limitations. J Clin Epidemiol. 2006 Aug; 59(8):808-18. PMID: 16828674.
      Citations:    
    115. Koester S, Glanz J, Barón A. Drug sharing among heroin networks: implications for HIV and hepatitis B and C prevention. AIDS Behav. 2005 Mar; 9(1):27-39. PMID: 15812611.
      Citations:    
    116. France EK, Glanz JM, Xu S, Davis RL, Black SB, Shinefield HR, Zangwill KM, Marcy SM, Mullooly JP, Jackson LA, Chen R. Safety of the trivalent inactivated influenza vaccine among children: a population-based study. Arch Pediatr Adolesc Med. 2004 Nov; 158(11):1031-6. PMID: 15520339.
      Citations:    
    117. Koester S, Heimer R, Barón AE, Glanz J, Teng W. Re: "Risk of hepatitis C virus among young adult injection drug users who share injection equipment". Am J Epidemiol. 2003 Feb 15; 157(4):376; author reply 376-8. PMID: 12578809.
      Citations:    
    118. Glanz J, Grant B, Monteiro M, Tabakoff B. WHO/ISBRA Study on State and Trait Markers of Alcohol Use and Dependence: analysis of demographic, behavioral, physiologic, and drinking variables that contribute to dependence and seeking treatment. International Society on Biomedical Research on Alcoholism. Alcohol Clin Exp Res. 2002 Jul; 26(7):1047-61. PMID: 12170115.
      Citations:    
    119. Hoffman PL, Glanz J, Tabakoff B. Platelet adenylyl cyclase activity as a state or trait marker in alcohol dependence: results of the WHO/ISBRA Study on State and Trait Markers of Alcohol Use and Dependence. Alcohol Clin Exp Res. 2002 Jul; 26(7):1078-87. PMID: 12170118.
      Citations:    
    120. Snell LD, Glanz J, Tabakoff B. Relationships between effects of smoking, gender, and alcohol dependence on platelet monoamine oxidase-B: activity, affinity labeling, and protein measurements. Alcohol Clin Exp Res. 2002 Jul; 26(7):1105-13. PMID: 12170121.
      Citations:    
    121. Tabakoff B, Helander A, Conigrave KM, Martinez L, Hoffman PL, Whitfield J, Degenhardt L, Saunders J, Barón A, Glanz J. WHP/ISBRA study on state and trait markers in alcoholism. Alcohol Clin Exp Res. 2001 May; 25(5 Suppl ISBRA):99S-103S. PMID: 11391057.
      Citations:    
    122. Ruttenber AJ, Harrison LT, Baron A, McClure D, Glanz J, Quillin R, O'Neill JP, Sullivan L, Campbell J, Nicklas JA. hprt mutant frequencies, nonpulmonary malignancies, and domestic radon exposure: "postmortem" analysis of an interesting hypothesis. Environ Mol Mutagen. 2001; 37(1):7-16. PMID: 11170237.
      Citations:    
    Concepts (326)
    Explore
    _
    Co-Authors (21)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _
    -->

    © 2021 Kaiser Permanente

    KP Researcher Profiles is made possible with the support of the Kaiser Permanente Research.